TALWIN TABLET
Nchi: Kanada
Lugha: Kiingereza
Chanzo: Health Canada
Tabia za bidhaa
(SPC)
22-05-2018
Hati zingine za bidhaa hii hazipatikani kwa sasa, unaweza kutuma ombi kwa huduma ya wateja wetu na tutakuarifu mara tu tutakapopata.
Tuma ombi.
Tuma ombi.
Viambatanisho vya kazi:
PENTAZOCINE (PENTAZOCINE HYDROCHLORIDE)
Inapatikana kutoka:
SANOFI-AVENTIS CANADA INC
ATC kanuni:
N02AD01
INN (Jina la Kimataifa):
PENTAZOCINE
Kipimo:
50MG
Dawa fomu:
TABLET
Tungo:
PENTAZOCINE (PENTAZOCINE HYDROCHLORIDE) 50MG
Njia ya uendeshaji:
ORAL
Vitengo katika mfuko:
100/500
Dawa ya aina:
Narcotic (CDSA I)
Eneo la matibabu:
OPIATE PARTIAL AGONISTS
Bidhaa muhtasari:
Active ingredient group (AIG) number: 0108852002; AHFS:
Idhini hali ya:
CANCELLED POST MARKET
Idhini ya tarehe:
2021-02-19
Tabia za bidhaa
_Page 1 of 32 _
PRESCRIBING INFORMATION
INCLUDING PATIENT MEDICATION INFORMATION
Ⓝ
TALWIN
®
pentazocine hydrochloride
Tablets, 50 mg
Narcotic Analgesic
sanofi-aventis Canada Inc.
2905 Place Louis-R.-Renaud
Laval, Quebec H7V 0A3
Date of Revision:
May 22, 2018
Submission Control No: 213122
_Page 2 of 32 _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
...................................................................................................3
WARNINGS AND PRECAUTIONS
..................................................................................4
ADVERSE REACTIONS
..................................................................................................13
DRUG INTERACTIONS
..................................................................................................15
DOSAGE AND ADMINISTRATION
..............................................................................16
OVERDOSAGE
................................................................................................................19
ACTION AND CLINICAL PHARMACOLOGY
............................................................19
STORAGE AND STABILITY
..........................................................................................21
DOSAGE FORMS, COMPOSITION AND PACKAGING
.............................................21
PART II: SCIENTIFIC INFORMATION
...............................................................................23
PHARMACEUTICAL INFORMATION
..........................................................................23
PART III: CONSUMER MEDICATION INFORMATION
..................................................24
_Page 3 of 32 _
Ⓝ
TALWIN
®
pentazocine hydrochloride tablets
PART I: HEALTH PROFESSIONAL INFORMATI
Soma hati kamili
